# Carnitine as an Adjunct to Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder

> **NCT01099072** · PHASE2 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 40 (estimated)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Methylphenidate+placebo
- **DRUG:** methylphenidate+carnitine

## Key facts

- **NCT ID:** NCT01099072
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-04
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2012-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01099072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01099072, "Carnitine as an Adjunct to Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01099072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*